The Importance of p16 and p53 Immunohistochemical Staining in Diagnosing Vulvar Lichen Simplex Chronicus Mimicking Vulvar Intraepithelial Neoplasia with False-Positive Human Papillomavirus Type 66
Pati Achdiat,Muhamad Widjaya,Rasmia Rowawi,Hermin Usman,Retno Maharani
DOI: https://doi.org/10.2147/ijwh.s439825
2024-01-05
International Journal of Women s Health
Abstract:Pati Aji Achdiat, 1 Muhamad Radyn Haryadi Widjaya, 1 Rasmia Rowawi, 1 Hermin Aminah Usman, 2 Retno Hesty Maharani 1 1 Department of Dermatology and Venereology, Faculty of Medicine, Universitas Padjadjaran Dr. Hasan Sadikin Hospital, Bandung, West Java, Indonesia; 2 Department of Anatomical Pathology, Faculty of Medicine, Universitas Padjadjaran Dr. Hasan Sadikin Hospital, Bandung, West Java, Indonesia Correspondence: Pati Aji Achdiat, Department of Dermatology and Venereology, Faculty of Medicine, Universitas Padjadjaran - Dr. Hasan Sadikin Hospital, Jl. Pasteur 38, Bandung, West Java, 40161, Indonesia, Tel +62222032426 ext 3449, Fax +62222032426, Email Vulvar intraepithelial neoplasia (VIN), the precursor lesion of vulvar squamous cell carcinoma (VSCC), may present as pruritic or asymptomatic lichenified plaques surrounded by single or multiple discrete or confluent macules or papules. VIN is divided into high-grade squamous intraepithelial lesion (HSIL), which is human papillomavirus (HPV)-driven, and differentiated VIN (DVIN), which develops independently of HPV. Histopathological examination and HPV genotyping polymerase chain reaction (PCR) tests should be performed to distinguish between HSIL and DVIN. Lichenified plaques surrounded by multiple papules are found not only in VIN but also in vulvar lichen simplex chronicus (LSC). This chronic inflammatory skin disease mostly appears in labia majora and is triggered by sweating, rubbing, and mental stress. IHC staining of p16 and p53 are recommended as the most commonly used biomarkers for VIN in diagnostically challenging cases. IHC staining is also beneficial to confirm the accuracy of the HPV detection technique, as p16-negative staining may also represent a false-positive result. We report a case of the importance of p16 and p53 IHC staining in diagnosing vulvar LSC mimicking VIN with false-positive HPV-66. The patient was previously diagnosed with VIN based on clinical examination. HPV-66 was detected by PCR from a vulvar biopsy sample. Histopathological examination revealed stromal lymphocytic infiltration with non-specific chronic dermatitis; neither atypia nor koilocyte was observed. Both p16 and p53 IHC staining were negative. The patient was diagnosed and treated as vulvar LSC with 10 mg cetirizine tablet, emollient, and 0.1% mometasone furoate cream. Clinical improvement was observed as the lesions became asymptomatic hyperpigmented macules in the 4 weeks of follow-up, without recurrence after 3 years of follow-up. Both p16 and p53 IHC staining might help distinguish HSIL and DVIN mutually and from other vulvar mimics in diagnostically challenging cases. Keywords: immunohistochemical staining, p16, p53, vulvar intraepithelial neoplasia, vulvar lichen simplex chronicus In 1982, the term vulvar intraepithelial neoplasia (VIN) was introduced by Crum et al, 1 replacing the confusing array of terms used at the time to describe precursor lesions of vulvar squamous cell carcinoma (VSCC). 2 The World Health Organization (WHO) classified VIN into high-grade squamous intraepithelial lesions (HSIL) and differentiated VIN (DVIN) according to the different pathogenesis of VSCC. HSIL covers all human papillomavirus (HPV)-associated intraepithelial lesions. In contrast, DVIN refers to HPV-independent lesions that generally develop in the context of dermatoses. 3 Therefore, histopathological examination and HPV genotyping polymerase chain reaction (PCR) are required to distinguish between HSIL and DVIN. 4 Human papillomaviruses (HPVs) are small, non-enveloped, epitheliotropic, double-stranded deoxyribose nucleic acid (DNA) viruses and are primarily found in sexually active women and men. The virus consists of several genotypes, which are further categorized as low-risk HPV (LR-HPV) and high-risk HPV (HR-HPV). 5,6 LR-HPV genotypes, including HPV-6, 11, 40, 42, 43, 44, 54, 61, 70, 72, and 81, cause genital warts and low-grade squamous intraepithelial lesions (LSIL) that seldom progress to cancerous lesions. HR-HPV, including HPV-16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 66, play a crucial role in the pathophysiology of either precancerous HSIL type of VIN 5 or malignancies on the cervix, anus, oropharynx, vulva, and penis. 6 However, some literatures report that the inclusion of HR-HPV-66 in the HPV Array Test is an ongoing source of false-positive results. 7,8 Additionally, in areas other than the cervix, such as the vulva, head, or neck, HPV infection cannot be reliably diagnosed by the detection of HPV DNA alone. Even de Sanjose et al 9 reported that HPV-66 was not detected in among 509 cases of HPV-positive VIN from 39 countries. Thus, further test such as p16 immunohistochemistry (IHC) is -Abstract Truncated-
obstetrics & gynecology